Prometheus Biosciences, Inc.
USD199.92
+0.18 (+0.09%)
CEO
Mark C. McKenna
IPO Date
2021-03-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$199.68
Prev. Close
$199.74
Day Low
$199.92
Day High
$199.96
52W Low
$23.27
52W High
$199.96
Market Cap
$9.56B
Volume
1.79M
| -13.8 |
| 31 Dec 2020 | FY | 100.0% | -3193.9% | 40.2% | -65.8% | -0.08 | 3.77 | -22.3 |
| 31 Dec 2019 | FY | 100.0% | -2727.5% | 82.5% | -60.4% | 0.00 | 1.18 | -22.4 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -109.4% | -71.5% | 1.21 | 6.39 | -9.4 |
| 31 Dec 2015 | FY | 0.0% | 0.0% | -68.0% | -47.1% | 0.22 | 5.50 | -7.3 |
| 31 Dec 2014 | FY | 100.0% | -26659.8% | -71.5% | -46.9% | 0.36 | 9.53 | -11.6 |
| -30.5 |
| 30 Sept 2022 | Q3 | 100.0% | -3736.3% | -15.6% | -12.1% | 0.13 | 11.19 | -16.8 |
| 30 Jun 2022 | Q2 | 100.0% | -2626.2% | -17.4% | -14.0% | 0.08 | 13.32 | -8.3 |
| 31 Mar 2022 | Q1 | 100.0% | -817.5% | -15.5% | -12.6% | 0.07 | 13.56 | -11.5 |
| 31 Dec 2021 | Q4 | 100.0% | -3048.6% | -13.4% | -11.8% | 0.00 | 16.14 | -12.2 |
| 30 Sept 2021 | Q3 | 100.0% | -2717.0% | -10.4% | -9.5% | 0.00 | 19.02 | -8.4 |
| 30 Jun 2021 | Q2 | 100.0% | -5827.9% | -6.7% | -6.1% | 0.03 | 17.61 | -12.5 |
| 31 Mar 2021 | Q1 | 100.0% | -1834.9% | -4.6% | -4.4% | 0.02 | 36.26 | -12.0 |
| 31 Dec 2020 | Q4 | 100.0% | -1862.4% | 8.8% | -14.5% | -0.08 | 3.77 | -19.8 |